Epidemiologic association between FUT2 secretor status and severe rotavirus gastroenteritis in children in the United States

JAMA Pediatrics

Volumn 169, Issue 11, 2015, Pages 1040-1045

  Payne, Daniel C ^a   Currier, Rebecca L ^b   Staat, Mary A ^b   Sahni, Leila C ^c   Selvarangan, Rangaraj ^d   Halasa, Natasha B ^e   Englund, Janet A ^f   Weinberg, Geoffrey A ^g   Boom, Julie A ^c,h   Szilagyi, Peter G ^g   Klein, Eileen J ^f   Chappell, James ^e   Harrison, Christopher J ^d   Davidson, Barbara S ^b   Mijatovic Rustempasic, Slavica ^a   Moffatt, Mary D ^d   McNeal, Monica ^b   Wikswo, Mary ^a   Bowen, Michael D ^a   Morrow, Ardythe L ^b   Parashar, Umesh D ^a   more..

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c Texas Children's Hospital   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f SEATTLE CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA [1,2] FUCOSYLTRANSFERASE 2; FUCOSYLTRANSFERASE; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG; GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE;

ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; GASTROENTERITIS; GENETIC ASSOCIATION; GENOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VACCINATION; VOMITING; CLINICAL TRIAL; FECES; GENETIC PREDISPOSITION; GENETICS; INFANT; ISOLATION AND PURIFICATION; MUTATION; NEWBORN; PROSPECTIVE STUDY; ROTAVIRUS; ROTAVIRUS INFECTIONS; SALIVA; VIROLOGY;

CASE-CONTROL STUDIES; CHILD, PRESCHOOL; FECES; FEMALE; FUCOSYLTRANSFERASES; GASTROENTERITIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PROSPECTIVE STUDIES; ROTAVIRUS; ROTAVIRUS INFECTIONS; SALIVA; UNITED STATES;

EID: 84946771697     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2015.2002     Document Type: Article

References (33)

1. Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 2002;185(9):1335-1337.
2. Borén T, Falk P, Roth KA, Larson G, Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262(5141):1892-1895.
3. Glass RI, Holmgren J, Haley CE, et al. Predisposition for cholera of individuals with O blood group: possible evolutionary significance. Am J Epidemiol. 1985;121(6):791-796.
4. Van Trang N, Vu HT, Le NT, Huang P, Jiang X, Anh DD. Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol. 2014;52(5): 1366-1374.
5. Imbert-Marcille BM, Barbé L, Dupé M, et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J Infect Dis. 2014;209(8):1227-1230.
6. Nordgren J, Sharma S, Bucardo F, et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis. 2014;59(11): 1567-1573.
7. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122(6):1235-1243.
8. Payne DC, Szilagyi PG, Staat MA, et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J. 2009;28(11):948-953.
9. Das BK, Gentsch JR, Cicirello HG, et al. Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol. 1994;32(7): 1820-1822.
10. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992;30 (6):1365-1373.
11. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990;28(2):276-282.
12. Griffin DD, Nakagomi T, Hoshino Y, et al; National Rotavirus Surveillance System. Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6], G12) and rare P3[9] strains related to bovine rotaviruses. Virology. 2002;294(2):256-269.
13. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther. 2011;13(1):101.
14. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5(6):e1000529.
15. Ferrer-Admetlla A, Sikora M, Laayouni H, et al. A natural history of FUT2 polymorphism in humans. Mol Biol Evol. 2009;26(9):1993-2003.
16. Hu L, Crawford SE, Czako R, et al. Cell attachment protein VP8∗ of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature. 2012;485(7397):256-259.
17. Liu Y, Huang P, Tan M, et al. Rotavirus VP8∗: phylogeny, host range, and interaction with histo-blood group antigens. J Virol. 2012;86(18): 9899-9910.
18. Lindesmith L, Moe C, Marionneau S, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003;9(5):548-553.
19. Carlsson B, Kindberg E, Buesa J, et al. The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 norovirus infection. PLoS One. 2009;4(5): e5593.
20. Currier RL, Payne DC, Staat MA, et al. Innate susceptibility to norovirus infections influenced by FUT2 genotype in a United States pediatric population. Clin Infect Dis. 2015;60(11):1631-1638.
21. Atmar RL, Opekun AR, Gilger MA, et al. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014;209(7):1016-1022.
22. Jones MK, Watanabe M, Zhu S, et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science. 2014;346(6210):755-759.
23. Böhm R, Fleming FE, Maggioni A, et al. Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion. Nat Commun. 2015;6: 5907.
24. Bucardo F, Kindberg E, Paniagua M, et al. Genetic susceptibility to symptomatic norovirus infection in Nicaragua [published correction appears in J Med Virol. 2009;81(6):1129]. J Med Virol. 2009;81(4):728-735.
25. Yen C, Steiner CA, Barrett M, et al. Racial disparities in diarrhea-associated hospitalizations among children in five US States, before and after introduction of rotavirus vaccine. Vaccine. 2010;28 (46):7423-7426.
26. Holman RC, Parashar UD, Clarke MJ, Kaufman SF, Glass RI. Trends in diarrhea-associated hospitalizations among American Indian and Alaska native children, 1980-1995. Pediatrics. 1999;103 (1):E11.
27. Linhares AC, Velázquez FR, Pérez-Schael I, et al; Human Rotavirus Vaccine Study Group. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008; 371(9619):1181-1189.
28. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009;301(21):2243-2251.
29. Yen C, Figueroa JR, Uribe ES, et al. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis. 2011;204(5):783-786.
30. Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America-a review. Mem Inst Oswaldo Cruz. 2011; 106(8):907-911.
31. Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013;57(1): 13-20.
32. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010; 125(2):e199-e207.
33. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr. 2005;135(5): 1304-1307.